| Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal M Shakya, R Colin-Jones, K Theiss-Nyland, M Voysey, D Pant, N Smith, ... New England Journal of Medicine 381 (23), 2209-2218, 2019 | 161 | 2019 |
| Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial M Shakya, M Voysey, K Theiss-Nyland, R Colin-Jones, D Pant, A Adhikari, ... The Lancet Global Health 9 (11), e1561-e1568, 2021 | 63 | 2021 |
| Impaired alanine transport or exposure to D-cycloserine increases the susceptibility of MRSA to β-lactam antibiotics LA Gallagher, RK Shears, C Fingleton, L Alvarez, EM Waters, J Clarke, ... The Journal of infectious diseases 221 (6), 1000-1016, 2020 | 17 | 2020 |
| Epidemiological and Molecular Characterization of an Invasive Group A Streptococcus emm32.2 Outbreak JE Cornick, AM Kiran, R Vivancos, J Van Aartsen, J Clarke, E Bevan, ... Journal of clinical microbiology 55 (6), 1837-1846, 2017 | 15 | 2017 |
| Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection J Clarke, M Baltazar, M Alsahag, S Panagiotou, M Pouget, WA Paxton, ... Scientific Reports 11 (1), 19011, 2021 | 8 | 2021 |
| Association of antibody-dependent neutrophil phagocytosis with distinct antibody glycosylation profiles following typhoid vaccination M Johnson, L Stockdale, N de Haan, M Wuhrer, J Nouta, CAM Koeleman, ... Frontiers in Tropical Diseases 2, 742804, 2021 | 3 | 2021 |
| Efficacy of typhoid conjugate vaccine in nepal: an interim analysis of a participant-and observer-blinded randomized phase III trial M Shakya, R Colin-Jones, K Theiss-Nyland, M Voysey, D Pant, N Smith, ... The New England Journal of Medicine 381 (23), 2209, 2019 | 3 | 2019 |
| A service evaluation of current practices in the assessment of mental-health and referral for support following disclosure of sexual violence J Clarke, A Hyde, RJ Caswell International journal of STD & AIDS 34 (1), 62-66, 2023 | 2 | 2023 |
| Identifying opportunities to improve the microbiological diagnosis of Tuberculosis in a low endemic urban setting J Clarke, M Moore, MK O’Shea, M Dedicoat Journal of Infection, 2023 | | 2023 |
| An alanine permease mutation or exposure to d-cycloserine increases the susceptibility of MRSA to β-lactam antibiotics LA Gallagher, RK Shears, C Fingleton, L Alvarez, EM Waters, J Clarke, ... bioRxiv, 616920, 2019 | | 2019 |
| Streptolysin production and activity is central to in vivo pathotype and disease outcome in GAS infections J Clarke, M Baltazar, M Alsahag, S Panagiotou, M Pouget, WA Paxton, ... bioRxiv, 686303, 2019 | | 2019 |
| Erratum for Cornick et al., “Epidemiological and Molecular Characterization of an Invasive Group A Streptococcus emm32.2 Outbreak” JE Cornick, AM Kiran, R Vivancos, J Van Aartsen, J Clarke, E Bevan, ... Journal of Clinical Microbiology 56 (9), 10.1128/jcm. 01001-18, 2018 | | 2018 |
Aras KadiogluProfessor of Bacterial Pathogenesis, Institute of Infection & Global Health, University of LiverpoolE-mail confirmado em liv.ac.uk
